We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · January 17, 2021

Neutralizing Anti-Emicizumab Antibody in Hemophilia A

Journal of Thrombosis and Haemostasis (JTH)


Additional Info

Journal of Thrombosis and Haemostasis (JTH)
Characterization of the Neutralizing Anti-Emicizumab Antibody in a Patient With Haemophilia A and Inhibitor
J. Thromb. Haemost. 2020 Dec 28;[EPub Ahead of Print], C Valsecchi, M Gobbi, M Beeg, T Adams, G Castaman, L Schiavone, JA Huntington, F Peyvandi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading